Physician profile
Lenora I Felderman
NPI 1235264011
$623.07
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $268 · 2020: $91.86 · 2021: $71.91 · 2022: $163 · 2023: $28.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $28.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $28.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $167.38 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $125.00 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $58.00 | 2019-2021 | |
| Vyne Pharmaceuticals INC. | $53.32 | 2020 | |
| Pfizer INC. | $53.25 | 2019-2021 | |
| Galderma Laboratories, L.P. | $41.83 | 2020-2021 | |
| Amgen INC. | $28.50 | 2023 | Enbrel, Otezla |
| Incyte Corporation | $27.00 | 2021-2022 | |
| Sebela Pharmaceuticals INC. | $22.67 | 2022 | |
| Sun Pharmaceutical Industries INC. | $17.85 | 2020 | |
| Mayne Pharma Commercial LLC | $15.77 | 2019 | |
| Dermira, INC. | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lenora Felderman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.